Advancing Excellence in Peptide Research
3rd Party Tested in the USA
$69.95
Adipotide is an experimental peptide designed to promote targeted fat loss by inducing apoptosis in adipocytes. While early animal research shows promising reductions in body fat and improvements in metabolic health, Adipotide is not approved for human use and lacks adequate clinical evidence regarding safety and effectiveness. Extreme caution is advised, along with consultation with healthcare professionals, for anyone considering its exploration.
Adipotide, also known as ADF-16, was developed in the early 2000s by researchers at the University of California, Los Angeles (UCLA). It was created as a targeted therapeutic approach to reduce adipose (fat) tissue through a unique biological mechanism. Adipotide is a synthetic peptide that induces apoptosis (programmed cell death) in adipocytes (fat cells). It works by binding to specific receptors located on the blood vessels that supply adipose tissue. This causes those blood vessels to collapse, cutting off the nutrient supply and triggering fat cell death. This mechanism sets Adipotide apart from traditional weight loss methods, which primarily focus on appetite suppression, caloric restriction, or stimulating metabolism. Early animal studies showed significant reductions in body fat, sparking interest in its potential application for obesity and metabolic disorders.
The potential benefits of Adipotide include:
Targeted Fat Loss
Adipotide specifically targets adipose tissue—especially visceral fat, which is associated with increased risk of metabolic diseases.
Weight Reduction
Animal studies have shown significant decreases in body weight and fat mass, while preserving lean muscle tissue.
Improved Metabolic Health
Reducing fat mass may lead to improvements in metabolic markers such as insulin sensitivity, blood glucose levels, and lipid profiles.
Adipotide is not approved by the FDA or other regulatory agencies for human use. It is an experimental compound and has not undergone sufficient clinical trials to establish safety, efficacy, or appropriate dosing in humans.
As with any research peptide, sourcing from a reputable supplier is critical to reduce risks associated with contamination, impurities, or mislabeling.
Human safety data is extremely limited. In animal studies, potential side effects have included:
appetite changes
metabolic disturbances
localized injection site reactions
possible kidney-related effects in higher doses
Long-term use has not been evaluated, and risks remain largely unknown.
Due to its experimental status, individuals should consult a qualified healthcare provider before considering any use. Medical supervision is strongly recommended to monitor potential side effects or complications.
| Amount | 2 mg, 5 mg |
|---|
Reviews
There are no reviews yet.